Multiple Myeloma RF

Cancer research efforts are often independent and disconnected. MMRF Virtual Lab® changes that. Learn More: bit.ly/4v7YZrc

NEWS: The FDA has approved a new wearable, subcutaneous delivery option for Sarclisa® (isatuximab-irfc) for certain multiple myeloma patients. This could mean less time in the clinic and a more convenient treatment experience. Learn more: themmrf.org/mmrf-blogs/sar…

One week left. MMRF Research Fellowship Scholars applications must be submitted by July 15 at 11:59 PM ET. You could receive $75K to pursue myeloma research. More info: themmrf.org/wp-content/upl…

When Eric Dillon started feeling pain in his shoulder, he chalked it up to a strained rotator cuff. The aches became a part of daily life, but then he felt a burst of tremendous pain while doing yard work. Tests confirmed Dillon had multiple myeloma. cbsnews.com/news/multiple-…

If you were recently diagnosed with multiple myeloma, one of the most important steps you can take is finding a myeloma specialist. The Find a Specialist tool on our website is a great place to start: bit.ly/4eO3nqF

Create your own fundraising event to support the MMRF and help advance research, new treatments, and ultimately, a cure for myeloma. Get started: cyo.themmrf.org

Data will drive the next breakthroughs—and cures—in multiple myeloma. But we have a data siloing problem. That’s why we’re excited to launch MMRF Virtual Lab, the largest open-access clinical and genomic dataset on multiple myeloma. Learn more: bit.ly/4v7YZrc

The Multiple Myeloma Hub provides balanced, credible, and up-to-date medical education. This resource explores bispecific antibody treatment for #MultipleMyeloma, including considerations for CRS risk mitigation, recognition, and management. bit.ly/4ei29DK #myeloma

MMRF Chief Medical Officer Hearn Jay Cho, MD, PhD spoke with Patient Power about iberdomide, a medication that's part of a new class of agents called CELMoDs. Learn more: bit.ly/3QAs8gC

One week left. MMRF Scholars applications must be submitted by June 30 at 11:59 PM ET. You could receive $400K over 4 years to pursue myeloma research. More info: themmrf.org/wp-content/upl…

After being diagnosed with multiple myeloma in 2023, Spencer Swann didn't think running a marathon was possible. Then he ran the @ChiMarathon with the MMRF. Spencer proves life doesn't stop at diagnosis. Want to run for a cure? endurance.themmrf.org/team-mmrf

This Father's Day Jonathan Gluck, a 20-year myeloma survivor and dad of two, shares why he gives to the MMRF. Honor someone you love with a gift that gives families more time: donate.themmrf.org/events/584/don…

Researchers from @ClevelandClinic developed a new model that could help oncologists better identify patients at "ultra high risk" for myeloma and match them to more effective treatments. The model was developed using data from the MMRF. Read more: consultqd.clevelandclinic.org/machine-learni…

Join our free webinar on the latest updates from this year's #ASCO26 and #EHA2026. Learn about emerging therapies, treatment sequencing, options for relapsed disease, and more. Register: mmrf.webcasts.com/starthere.jsp?…

What a season for our walk community! 📈 $475,000+ raised for myeloma research 👟 2,000+ walkers 🤝 200+ teams Thank you to everyone who showed up for the myeloma community! Walk with us this fall: walk.themmrf.org

This past weekend, the 2026 European Hematology Association (EHA) Congress brought together researchers, physicians, and patient advocates to share the latest advances in blood cancer research. We rounded up the top takeaways for patients: bit.ly/4otYDJI

This Father's Day, honor someone you love with a gift that gives families more time: donate.themmrf.org/events/584/don…

Investigators at @DanaFarber developed a new risk prediction model for smoldering multiple myeloma called PANGEA-SMM, which outperformed existing models in a recent study published in @NatureMedicine: bit.ly/49WHMcA

Mariska Hargitay honors her father’s legacy by sharing his multiple myeloma story as part of BMS’s new “Investigating Myeloma” awareness campaign. In @CUREtoday, she highlights awareness + ongoing CELMoD research advancing treatment. Read more: bit.ly/4gcr4tC

Know an early-career myeloma researcher who should apply for the 2026 MMRF Scholars Program or the MMRF Research Fellowship Program? Tag them! Learn more: themmrf.org/for-researcher…